Employer record no. 25153
Fulcrum Therapeutics, Inc.
US DOL LCA disclosure data, FY2020 to FY2023
Total LCA filings
11
Certified
8
Denied
0
FY2023 filings
5
Filings by fiscal year
Peer rank
#2,392 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 4 | 4 | 0 | $147,500 | $107,141 |
| FY2022 | 2 | 2 | 0 | $127,500 | $112,102 |
| FY2023 | 5 | 2 | 0 | $172,000 | $142,817 |
What they file for
- senior manager, clinical data management$140,0003
- associate director-drug product development$165,0002
- principal scientist, target discovery & functional genomics$160,0002
- senior biostatistician$115,0002
- manager, regulatory affairs$105,0001
- senior director neuromuscular, medical affairs$300,0001
Where
- cambridge, ma8
- raritan, nj2
- smithtown, ny1
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Fulcrum Therapeutics, Inc. and any other employer they watch.
Certification rate 72.7%How these numbers are computed